Vilon 20mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Vilon supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety. Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques. Batch: GF-VILON20-B241 Key analytical results include:

• Assay Content: 23.5 mg
• Identification – Retention Time: 0.995
• Identification – Spectrum: 997
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium. These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

Vilon is a short synthetic peptide research compound frequently studied in controlled laboratory environments investigating cellular signalling pathways and peptide-mediated regulatory processes. The peptide belongs to a class of small regulatory peptides originally identified in thymic tissue and studied for their involvement in cellular communication and immune-related signalling systems. This preparation contains 20 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation. Because of its defined molecular structure and stable analytical profile, Vilon has become a recognised compound in experimental peptide research models.

Compound Overview

Vilon is a short synthetic peptide composed of two amino acids that has been investigated in laboratory research focused on peptide-mediated signalling pathways. Research involving Vilon frequently explores molecular communication systems within cells and the regulatory roles of small peptide fragments. Due to its compact structure and defined biochemical profile, the peptide is often used in experimental models examining intracellular signalling mechanisms and regulatory peptide activity.

Historical Background and Scientific Context

Scientific research into short regulatory peptides expanded during the late twentieth century as researchers began identifying numerous peptide fragments that influence cellular signalling. During this period, small peptides originating from thymic and regulatory tissues were investigated for their potential roles in cellular communication and biochemical regulatory networks. Vilon emerged as one of the short peptides studied within experimental research exploring peptide-mediated regulatory pathways.

Mechanistic Focus in Research

Within experimental laboratory settings, Vilon is commonly studied in relation to peptide signalling systems and intracellular regulatory pathways. Research investigations commonly explore the compound in experimental models examining:

• Peptide-mediated cellular signalling
• Intracellular regulatory mechanisms
• Short peptide interaction pathways
• Cellular communication networks
• Comparative peptide signalling research
• Protein and peptide regulatory modelling
• Molecular signalling pathway analysis

These experimental models allow scientists to investigate molecular regulatory mechanisms involved in cellular communication and peptide-mediated signalling processes.

Research Applications

In controlled research environments, Vilon may be utilised in experimental models designed to explore peptide signalling systems and intracellular regulatory networks. Examples of research applications include:

• Cell signalling pathway investigation
• Peptide interaction research
• Intracellular regulatory network modelling
• Comparative peptide compound studies
• Molecular signalling pathway analysis
• Short peptide regulatory mechanism research
• Controlled in vitro peptide signalling studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation. Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Verified and analysed with Liquilabs s.r.o. (Czechia)
Validated assay content of 23.5 mg
Purity greater than 99.8 percent
Retention time and spectral identity confirmation
Endotoxin levels below 0.001 EU per mg
No detectable microbial contamination
No detectable heavy metals
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.